Antibody molecules to LAG-3 and uses thereof
US9908936B2 · kind B2 · utility
17Cited by
22References
30Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 24, 2017 |
| Grant date | Mar 6, 2018 |
| Priority date | — |
| Expiry date | Mar 24, 2037 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/70596
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Antibody molecules that specifically bind to LAG-3 are disclosed. The anti-LAG-3 antibody molecules can be used to treat, prevent and/or diagnose cancerous or infectious disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.